Hematologic Diseases: Clinical Trials

188 trials for Hematologic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

188 unknown. 188 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4188Unknown 188

Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases

Trials (filtered) newest first · largest first

All 188 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
QL0605(PEG-rhG-CSF) - Chemotherapy-Induced Febrile Neutropenia
Phase 4UnknownQilu Pharmaceutical Co., Ltd.3362024-09-192024-09-27
A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA
Romiplostim - Aplastic Anemia
Phase 4UnknownPeking Union Medical College Hospital402024-08-022024-08-02
Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA
rhTPO, Cyclosporin A - Aplastic Anemia, Transfusion-dependent Anemia
Phase 4UnknownPeking Union Medical College Hospital542024-07-302024-07-29
Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm Study
Romiplostim - Aplastic Anemia
Phase 4UnknownPeking Union Medical College Hospital402024-07-302024-07-24
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
Hetrombopag - Thrombocytopenia
Phase 4UnknownThe Third People's Hospital of Chengdu552024-06-012024-08-20
A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag
Lusutrombopag - Aplastic Anemia
Phase 4UnknownPeking Union Medical College Hospital402024-06-012024-05-23
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
Tranexamic acid, No Tranexamic acid - Venous Thromboembolism, Venous Thromboses
Phase 4UnknownUniversity Health Network, Toronto202024-06-012024-06-12
A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation
Pentaisomaltose - Malignant Lymphoma, Multiple Myeloma
Phase 4UnknownPharmacosmos A/S1502024-04-302024-04-03
Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy
Ferrous Sulfate Oral Product - Cerebral Palsy, Iron Deficiency Anemia
Phase 4UnknownShaheed Zulfiqar Ali Bhutto Medical University1602024-02-012024-01-17
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency
Phase 4UnknownUniversity of Padova2582024-01-152023-12-15
Continuous Versus Bolus Administration of G-CSF in Children With Cancer
G-CSF administration (bolus injection versus intravenous infusion) - Pediatric Cancer, Neutropenia
Phase 4UnknownChang Gung Memorial Hospital202023-11-232024-09-19
The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA
Busulfan, Flu/Cy/ATG or Cy/ATG - Severe Aplastic Anemia
Phase 4UnknownPeking University People's Hospital1602023-11-152023-11-18
A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAA
Herombopag + CsA, rhTPO combined with Herombopag + CsA - Aplastic Anemia, Drug Effect
Phase 4UnknownPeking Union Medical College Hospital902023-08-012023-08-22
Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS
Roxadustat, Luspatercept - Myelodysplastic Syndromes
Phase 4UnknownPeking Union Medical College Hospital622023-08-012023-08-23
Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS
Lenalidomide, Azacitidine - Myelodysplastic Syndromes
Phase 4UnknownPeking Union Medical College Hospital1382023-08-012023-08-22
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
Intravenous iron sucrose, Lactoferrin - Iron Deficiency Anemia
Phase 4UnknownAin Shams University1002023-07-302023-07-19
Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient
Clonidine - Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease
Phase 4UnknownCentre Hospitalier Universitaire Saint Pierre402023-04-252023-05-08
Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients
Tocilizumab - Multiple Myeloma
Phase 4UnknownThe First Affiliated Hospital of Soochow University482023-04-172023-06-02
TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
TPO-RAs, TPO-RAs combining anti-CD 20 monoclonal antibody - Primary Immune Thrombocytopenia (ITP)
Phase 4UnknownInstitute of Hematology & Blood Diseases Hospital, China1662023-02-232024-07-30
Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System
CsA+ATG+Herombopag, CsA+Herombopag - Aplastic Anemia, CSA
Phase 4UnknownPeking Union Medical College Hospital2102023-01-202023-08-24

Showing 20 of 188. Sign in to see all of them.

Narrower conditions

Anemia (26)  ·  Anemia, Iron-Deficiency (23)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (17)  ·  Anemia, Aplastic (11)  ·  Leukemia, Myeloid, Acute (11)  ·  Purpura, Thrombocytopenic, Idiopathic (10)  ·  Multiple Myeloma (8)  ·  Thrombocytopenia (8)  ·  Hemophilia A (7)  ·  Neutropenia (7)  ·  Febrile Neutropenia (6)  ·  Hemorrhage (6)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (6)  ·  Myelodysplastic Syndromes (6)  ·  Neoplasms (6)

Broader conditions

Hemic and Lymphatic Diseases (188)  ·  Neoplasms (62)  ·  Neoplasms by Histologic Type (55)  ·  Pathological Conditions, Signs and Symptoms (53)  ·  Pathologic Processes (49)  ·  Anemia (47)  ·  Immune System Diseases (45)  ·  Leukemia (38)  ·  Cytopenia (33)  ·  Hemorrhagic Disorders (33)  ·  Lymphoproliferative Disorders (31)  ·  Immunoproliferative Disorders (30)  ·  Metabolic Diseases (28)  ·  Nutritional and Metabolic Diseases (28)

Interventions

Cytarabine (11)  ·  Dexamethasone (11)  ·  ferric carboxymaltose (11)  ·  Cyclophosphamide (9)  ·  Idarubicin (8)  ·  Granulocyte Colony-Stimulating Factor (5)  ·  Iron (5)  ·  Methotrexate (5)  ·  ferrous fumarate (5)  ·  fludarabine (5)  ·  Bortezomib (4)  ·  Busulfan (4)  ·  Cyclosporine (4)  ·  Decitabine (4)  ·  Doxorubicin (4)

Sponsors

Peking Union Medical College Hospital (14)  ·  Chinese Academy of Medical Sciences (3)  ·  Peking University People's Hospital (3)  ·  Shandong Provincial Hospital (3)  ·  Shandong University (3)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (3)  ·  Shenzhen Second People's Hospital (3)  ·  Sun Yat-sen University (3)  ·  The First Affiliated Hospital of Soochow University (3)  ·  Ain Shams University (2)  ·  Asan Medical Center (2)  ·  Assiut University (2)  ·  Chinese PLA General Hospital (2)  ·  Cttq (2)  ·  Hospital Clinic of Barcelona (2)

Countries

China (70)  ·  Egypt (9)  ·  United States (9)  ·  Spain (8)  ·  Germany (5)  ·  Italy (5)  ·  Netherlands (5)  ·  Brazil (4)  ·  Denmark (4)  ·  India (4)  ·  Taiwan (4)  ·  Israel (3)  ·  Mexico (3)  ·  Singapore (3)  ·  South Korea (3)

Top investigators

Adolfo Martinez Tovar, PhD (2)  ·  Bing Bing, PhD (2)  ·  Bing Han, PhD (2)  ·  Xiaofan Zhu, MD (2)  ·  Yanfang Li, PhD (2)  ·  Abraham V Hodgson, MD, MPH, PhD (1)  ·  Ahmed Elshahawy, MD (1)  ·  Ahmed F Elkoraie, Prof (1)  ·  Ahmed Kamel, M.D. (1)  ·  Ajay Vora (1)  ·  Alan Tinmouth (1)  ·  Albina Nowak, MD (1)

Results publications

PMID 19005182, PMID 10049409, PMID 10231138, PMID 10583235, PMID 1090310, PMID 11796024, PMID 11863096, PMID 12084168, PMID 12627513, PMID 14585365, PMID 15661401, PMID 16096770, PMID 16110027, PMID 16197446, PMID 16329022, PMID 1640190, PMID 17410187, PMID 17620512, PMID 17919504, PMID 18298856, PMID 18398750, PMID 18626005, PMID 19167677, PMID 19212255, PMID 19446149, PMID 19822296, PMID 19951974, PMID 20232087, PMID 20542125, PMID 20625136, PMID 20739054, PMID 20817366, PMID 20920599, PMID 20962160, PMID 21168455, PMID 21663651, PMID 21982521, PMID 22054810, PMID 22318524, PMID 22338149, PMID 22409309, PMID 22419305, PMID 22471345, PMID 22512017, PMID 22677206, PMID 2279341, PMID 22871557, PMID 22966847, PMID 23376821, PMID 23383989

NIH funding

2018 (2), 2005 (1), 2014 (1)